APA (7th ed.) Citation

N, L., A, S., SJ, H., D, C., FJ, B., KC, A., . . . M, T. (2016). Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients. British journal of haematology, 174(5), 711. https://doi.org/10.1111/bjh.14113

Chicago Style (17th ed.) Citation

N, Levin, Spencer A, Harrison SJ, Chauhan D, Burrows FJ, Anderson KC, Reich SD, Richardson PG, and Trikha M. "Marizomib Irreversibly Inhibits Proteasome to Overcome Compensatory Hyperactivation in Multiple Myeloma and Solid Tumour Patients." British Journal of Haematology 174, no. 5 (2016): 711. https://doi.org/10.1111/bjh.14113.

MLA (9th ed.) Citation

N, Levin, et al. "Marizomib Irreversibly Inhibits Proteasome to Overcome Compensatory Hyperactivation in Multiple Myeloma and Solid Tumour Patients." British Journal of Haematology, vol. 174, no. 5, 2016, p. 711, https://doi.org/10.1111/bjh.14113.